Displaying drugs 6601 - 6625 of 8115 in total
D-glyceraldehyde 3-phosphate
An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis.
Experimental
Erteberel
Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.
Experimental
Investigational
TOL-101
Investigational
CT-001
Investigational
Recombinant human palmitoyl protein thioesterase-1
Investigational
WSD-0922
Investigational
Matched Synonyms: … (r)-6-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-n-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine …
Matched Salts name: … (R)-6-((3,3-Difluoro-1-Methylpiperidine-4-Yl)Oxy-N-(3-Ethynyl-2-Fluorophenyl)-7-Methoxyquinazolin-4-Amine …
Matched Salts name: … (R)-6-((3,3-Difluoro-1-Methylpiperidine-4-Yl)Oxy-N-(3-Ethynyl-2-Fluorophenyl)-7-Methoxyquinazolin-4-Amine …
TALL-104
Investigational
Interferon alfa-1b
Investigational
Iodamide
Iodamide is a contrast medium molecule that is no longer marketed in the United States.
Withdrawn
Matched Iupac: … 3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid …
Sulopenem
Sulopenem is under investigation in clinical trial NCT03357614 (Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults).
Investigational
Matched Iupac: … (1R,3S)-3-{[(5R,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-en-3-yl] …
2,6-Diamino-Hexanoic Acid Amide
Experimental
Matched Iupac: … (5S)-5-amino-5-carbamoylpentan-1-aminium …
Talampicillin
Experimental
Matched Iupac: … 3-oxo-1,3-dihydro-2-benzofuran-1-yl (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo- …
Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester
Experimental
Matched Name: … Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester …
Hydrocortisone aceponate
Experimental
Vet approved
Gibberellin A4
Experimental
Matched Iupac: … (1R,2R,5R,8R,9S,10R,11S,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1^{5,8} …
Nalorphine
Nalorphine is a mixed opioid agonist–antagonist. It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence.
Experimental
Vet approved
Matched Iupac: … (1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca …
Icotinib
Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational
Buthionine sulfoximine
Buthionine sulfoximine has been used in trials studying the treatment of Neuroblastoma and Melanoma (Skin).
Investigational
Matched Synonyms: … DL-buthionine-(S,R)-sulfoximine …
(2S)-2,3-Diaminobutanoic acid
Experimental
Displaying drugs 6601 - 6625 of 8115 in total